781 related articles for article (PubMed ID: 28337021)
1. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
Dickey SW; Cheung GYC; Otto M
Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
[TBL] [Abstract][Full Text] [Related]
2. Bacterial adhesion--a source of alternate antibiotic targets.
Cusumano CK; Hultgren SJ
IDrugs; 2009 Nov; 12(11):699-705. PubMed ID: 19844856
[TBL] [Abstract][Full Text] [Related]
3. Novel agents to inhibit microbial virulence and pathogenicity.
Escaich S
Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
[TBL] [Abstract][Full Text] [Related]
4. Antivirulence compounds: a future direction to overcome antibiotic resistance?
Buroni S; Chiarelli LR
Future Microbiol; 2020 Mar; 15():299-301. PubMed ID: 32286100
[No Abstract] [Full Text] [Related]
5. Targeting virulence not viability in the search for future antibacterials.
Heras B; Scanlon MJ; Martin JL
Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
[TBL] [Abstract][Full Text] [Related]
6. Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.
Ogawara H
J Antibiot (Tokyo); 2021 Jan; 74(1):24-41. PubMed ID: 32647212
[TBL] [Abstract][Full Text] [Related]
7. Disarming pathogens: benefits and challenges of antimicrobials that target bacterial virulence instead of growth and viability.
Totsika M
Future Med Chem; 2017 Mar; 9(3):267-269. PubMed ID: 28207349
[No Abstract] [Full Text] [Related]
8. Specific Antivirulence Activity, A New Concept for Reliable Screening of Virulence Inhibitors.
Defoirdt T
Trends Biotechnol; 2016 Jul; 34(7):527-529. PubMed ID: 26879186
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
Guillard T; Pons S; Roux D; Pier GB; Skurnik D
Bioessays; 2016 Jul; 38(7):682-93. PubMed ID: 27248008
[TBL] [Abstract][Full Text] [Related]
10. Anti-virulence strategies to combat bacteria-mediated disease.
Rasko DA; Sperandio V
Nat Rev Drug Discov; 2010 Feb; 9(2):117-28. PubMed ID: 20081869
[TBL] [Abstract][Full Text] [Related]
11. Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.
Russo TA; Spellberg B; Johnson JR
J Infect Dis; 2016 Mar; 213(6):901-3. PubMed ID: 26563238
[TBL] [Abstract][Full Text] [Related]
12. Quorum quenching agents: resources for antivirulence therapy.
Tang K; Zhang XH
Mar Drugs; 2014 May; 12(6):3245-82. PubMed ID: 24886865
[TBL] [Abstract][Full Text] [Related]
13. Anti-virulence Strategies to Target Bacterial Infections.
Mühlen S; Dersch P
Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
[TBL] [Abstract][Full Text] [Related]
14. The biology and future prospects of antivirulence therapies.
Cegelski L; Marshall GR; Eldridge GR; Hultgren SJ
Nat Rev Microbiol; 2008 Jan; 6(1):17-27. PubMed ID: 18079741
[TBL] [Abstract][Full Text] [Related]
15. Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era.
Neville N; Jia Z
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678155
[TBL] [Abstract][Full Text] [Related]
16. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.
Scoffone VC; Trespidi G; Chiarelli LR; Barbieri G; Buroni S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013936
[TBL] [Abstract][Full Text] [Related]
17. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
[TBL] [Abstract][Full Text] [Related]
18. Antivirulence as a new antibacterial approach for chemotherapy.
Escaich S
Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647
[TBL] [Abstract][Full Text] [Related]
19. Approaches targeting the type III secretion system to treat or prevent bacterial infections.
Charro N; Mota LJ
Expert Opin Drug Discov; 2015 Apr; 10(4):373-87. PubMed ID: 25727140
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance.
Frieri M; Kumar K; Boutin A
J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
